Sugi Predict

Sugi Predict / Targets / NAF1

NAF1

H/ACA ribonucleoprotein complex non-core subunit NAF1 · Q96HR8 · NAF1 on Sugi Atlas →

0 patent compounds predicted against NAF1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to NAF1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS PHASE2COMPLETED
Trial of the Histone-Deacetylase Inhibitor ITF2357 Followed by Mechlorethamine in Relapsed/Refractory Hodgkin's Lymphoma PHASE1/PHASE2COMPLETED
Reverse Transcriptase Inhibitors in AGS PHASE2COMPLETED
A Study of Bezafibrate in Mitochondrial Myopathy PHASE2COMPLETED
Thermogenic Silencer Regulatory Factors in Humans nanACTIVE_NOT_RECRUITING
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
Micro RNA Levels in NAFLD nanUNKNOWN
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
Epidemiology of Atherosclerosis nanCOMPLETED
X-chromosome Inactivation, Epigenetics and the Transcriptome nanCOMPLETED
Clinical Manifestations and Biomarkers in Amyotrophic Lateral Sclerosis Type 4 and Other Inherited Neurological Disorders of RNA Processing nanRECRUITING
Investigations Into ISCU Myopathy or Iron Sulfur Scaffold U Protein Myopathy nanCOMPLETED
A Study to Assess Variation in Potential Biomarkers in Friedreich Ataxia nanCOMPLETED
Effect of Adenovirus E1A Oncogene on DNA Replication Dynamics nanUNKNOWN
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Studying The Role of Key Epigenetic Mediators in Breast Cancer Patients nanRECRUITING
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Diagnosis of Inflammatory Bowel Disease nanNOT_YET_RECRUITING
Whole-genome Sequencing Study in Patients With Diminished Ovarian Reserve nanUNKNOWN
Nuclear Morphology of Breast Cells in Ductal Lavage nanCOMPLETED
Shwachman Diamond Syndrome Registry and Study nanRECRUITING
The Role of microRNAs in Organ Remodeling in Lower Urinary Tract Dysfunction nanCOMPLETED
Signs and Symptoms Associated With Molecular Defects in Genetically Inherited Heart Disease nanCOMPLETED
PHF19 Gene Expression and EZH2 Gene Deletion in Acute Myeloid Leukemia nanUNKNOWN
Role of the Nuclear Pore Component RANBP2 in Inflammatory Responses to Viral Infections nanCOMPLETED
Immunophenotyping and Xist Gene in AML nanUNKNOWN
Signs and Symptoms of Genetic Abnormalities Linked to Inherited Heart Disease nanCOMPLETED
Different Genetic Features Associated With Hepatic Carcinogenesis nanUNKNOWN
The LD Lync Study - Natural History Study of Lipodystrophy Syndromes nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a NAF1 binder may also engage these)

ProteinNameSimilarity
Q52KK4 — 1.000 Q52KK4 →
Q3UMQ8 — 1.000 Q3UMQ8 →
Q6A037 — 0.989 Q6A037 →
B2RRE7 — 0.988 B2RRE7 →
Q05A80 — 0.987 Q05A80 →
Q9UHK0 — 0.987 Q9UHK0 →
Q96T21 — 0.987 Q96T21 →
O18805 — 0.987 O18805 →
Q9CYA6 — 0.986 Q9CYA6 →
Q9JL04 — 0.986 Q9JL04 →
Q08E13 — 0.986 Q08E13 →
E1BE02 — 0.986 E1BE02 →
Q8R4I4 — 0.985 Q8R4I4 →
Q8RWK8 — 0.985 Q8RWK8 →
Q09003 — 0.985 Q09003 →
Q5R789 — 0.985 Q5R789 →
Q9QXX8 — 0.985 Q9QXX8 →
Q76LL6 — 0.985 Q76LL6 →
O75113 — 0.985 O75113 →
Q641W3 — 0.985 Q641W3 →
Q07G43 — 0.984 Q07G43 →
Q6ZQ03 — 0.984 Q6ZQ03 →
Q71RC2 — 0.984 Q71RC2 →
Q61464 — 0.984 Q61464 →
Q80XI3 — 0.984 Q80XI3 →
O08623 — 0.984 O08623 →
Q6NRI5 — 0.984 Q6NRI5 →
Q6DD45 — 0.984 Q6DD45 →
Q5RIX9 — 0.984 Q5RIX9 →
Q28EG9 — 0.984 Q28EG9 →